Stock Ticker

  • Loading stock data...

Inovio Pharmaceuticals Inc (NASDAQ:INO) Is Now Offering Common Stock To the Public For The Acquire

The current developments have shown that Inovio Pharmaceuticals Inc (NASDAQ:INO) has finally accepted to sell its shares to the public after a very long period of time of anticipation from the public. According to different sources, Inovio has already announced the pricing of underwritten public offering of 12,500,000 shares of its common stocks will be […]

Inovio Pharmaceuticals, Inc. (NASDAQ:INO), To Continue INO-1800 Development Amid Roche Holding Ltd. (OTCMKTS:RHHBY) Ditching

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has revealed on Wednesday that it will continue to independently develop INO-1800, a hepatitis B DNA immunotherapy, after Roche Holding Ltd. (OTCMKTS:RHHBY) decided to entirely discontinue collaborating with the company. Inovio’s Plans for INO-1800 Development The company will proceed with the randomized, open-label, active-controlled Phase I clinical trial of INO-1800 in […]

Ebola Fears: Drug And Suit Makers Up In The Market

Boston, MA 10/13/2014 (wallstreetpr) – The Ebola menace is slowly finding its way in the U.S. after a nurse who cared for an Ebola patient was also diagnosed with the virus. Companies developing cures for the diseases lead by Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) have been on an upward swing. Focus […]

Inovio Pharmaceuticals Inc (NASDAQ:INO) To Advance Development Of Ebola Vaccine To Human Trials

Boston, MA 09/25/2014 (wallstreetpr) – Inovio Pharmaceuticals Inc (NASDAQ:INO) and Seoul-based GeneOne Life Science Inc (KRX:011000) have announced plans to conduct human trial on Ebola vaccine by 2015. Inovio and GeneOne have advanced to the next level with their Ebola treating DNA vaccine and are seeking to start human trails by the next year. The two […]